Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3)
Clinical trial NCT03912532 · COMPLETED
Trial details
- NCT number
- NCT03912532
- Sponsor
- NGM Biopharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-16
- Primary completion
- 2021-03-04
- Enrollment
- 171
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.